Novavax, Inc. (NVAX) Posts Narrower than Expected Q4 Loss
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.35 +0.21%
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: -164.5%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q4 loss of $0.06, 3 cents better than the analyst estimate of ($0.09). Revenue for the quarter came in at $51 thousand versus the consensus estimate of $110 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- PriceSmart (PSMT) Misses Q3 EPS by 4c, Beats on Revenue
- Northern Technologies (NTIC) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
